Pantoprazole 40mg
CTNZ-2017-01
Phase 2 small_molecule completed
Quick answer
Pantoprazole 40mg for Oncology is a Phase 2 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Oncology
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed